ACOG urges expedited partner therapy for some STIs

ACOG urges expedited partner therapy for some STIs

(HealthDay)—For patients with sexually transmitted infections (STIs), such as gonorrhea and chlamydia, whose partners are unable or unwilling to seek care, expedited partner therapy can be used to prevent reinfection, according to a Committee Opinion published in the June issue of Obstetrics & Gynecology.

Researchers from the Committee on Gynecologic Practice and the Committee on Adolescent Health Care discuss use of expedited partner therapy to help prevent the high rates of STIs seen among young women, specifically from reinfection from an untreated sexual partner.

According to the report, expedited partner therapy allows obstetrician-gynecologists or other providers to prescribe medications to patients to take to their partners, without the need for examination of these partners. However, numerous legal, practical, and administrative barriers hinder routine use of expedited partner therapy. When a patient's partners are unwilling or unable to seek medical care, the American College of Obstetricians and Gynecologists supports use of expedited partner therapy for preventing and reinfection. Patient counseling and written instructions for the partner should be provided in addition to expedited partner therapy. Recipients of expedited partner therapy should be urged to seek additional medical evaluation as soon as possible to discuss STI screening.

"The College encourages members to advocate for the legalization of expedited partner therapy and to work with their health departments to develop protocols for its use," the authors write.


Explore further

AAP issues guidance on STI screening for teens

More information: Full Text
Journal information: Obstetrics & Gynecology

Copyright © 2015 HealthDay. All rights reserved.

Citation: ACOG urges expedited partner therapy for some STIs (2015, May 25) retrieved 18 September 2021 from https://medicalxpress.com/news/2015-05-acog-urges-partner-therapy-stis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
5 shares

Feedback to editors